SUMO2 pseudogene 13 (SUMO2P13)

SUMO2 pseudogene 13 (SUMO2P13) is classified as a pseudogene, meaning it shares sequence similarity with the gene encoding Small Ubiquitin-like Modifier 2 (SUMO2), but it is considered non-functional and does not produce a functional protein[3]. The canonical SUMO2 gene is involved in protein modification processes like nuclear transport, DNA repair, and transcription regulation[1][2][4][6]. However, pseudogenes like SUMO2P13 are by definition not active in encoding proteins or directly participating in cellular processes. Key Clarifications: - SUMO2P13 is a pseudogene, not a known therapeutic target, receptor, enzyme, or functional molecular entity. - There is no evidence to support a direct biological function, disease role, drug interaction, mechanism of action, or biomarker value for SUMO2P13[3]. - The entry is not appropriate as a drug target or for therapeutic purposes due to its non-functional status[3]. If the intended query was for the active SUMO2 gene, refer to "Small ubiquitin-like modifier 2 (SUMO2)" instead for meaningful biological and therapeutic information[1][2][4].

Other names

SUMO2P13SUMO2 pseudogene 13